Company · CIK 0001714899 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Denali Therapeutics Inc. · DNLI
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 SForm 4 → | Sep 9, 4:44 pm EDT | Peter Scott ChinChief Medical Officer | 1,654 | $22.29 | $36,868 | 204,538 | −0.80% | |
| Sep 2, 2026 SForm 4 → | Sep 4, 5:02 pm EDT | Nancy ThornberryDirector | 11,439 | $22.90 | $261,929 | 19,686 | −36.8% | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 3, 4:17 pm EDT | Alexander O. SchuthCOFO and Secretary | 2,768 | $23.44 | $64,882 | 278,995 | −0.98% | 10b5-1 |
| Aug 12, 2026 GForm 4 → | Aug 14, 4:48 pm EDT | Ryan J. WattsPresident and CEO, Director | 32,220 | — | — | 2,120,384 | — | |
| Aug 11, 2026 SForm 4 → | Aug 13, 5:01 pm EDT | Alexander O. SchuthCOFO and Secretary | 2,857 | $25.07 | $71,625 | 281,763 | −1.00% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.